RJ

Rakesh Jaysawal

Active Director Designated Partner DIN 09271532
DIN 09271532 First appointment Aug 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Aug 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Rakesh Jaysawal

Data last updated:

Rakesh Jaysawal is a Designated Partner at Medhost Pharma Llp (since 2021) and Director at Medplace Pharma Private Limited (since 2021). The companies operate in Healthcare and Pharma.

DIN 09271532
Primary Designation Designated Partner
Industry Healthcare
First Appointment 06 Aug 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner20 Aug 20212021Active
Medplace Pharma Private Limited U24230UP2021PTC150314
Director06 Aug 20212021Active

Board colleagues of Rakesh Jaysawal

Directorship timeline

Open interactive timeline →
Medhost Pharma Llp
Medplace Pharma Private Limited
Premium access

Shareholding and investment profile for Rakesh Jaysawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Jaysawal

Rakesh Jaysawal currently holds 2 directorships: Medhost Pharma Llp (Designated Partner, since 20 Aug 2021); Medplace Pharma Private Limited (Director, since 06 Aug 2021).

Rakesh Jaysawal was first appointed on 06 Aug 2021 as Director at Medplace Pharma Private Limited.

The current boards of Rakesh Jaysawal's companies include Brijesh Kumar Mishra (Medhost Pharma Llp), Girish Kumar Mishra (Medhost Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available